Kristina Johnson

Kristina Johnson has extensive experience in the field of clinical operations. Kristina is currently the Vice President of Clinical Operations at QurAlis, starting in September 2022. Prior to that, they worked at Dyne Therapeutics as the Executive Director and Head of Clinical Operations from April 2021 to June 2022. Kristina also held a role as a Senior Director at bluebird bio, focusing on clinical trial strategy and execution in the field of oncology from January 2021 to April 2021.

Before their time at bluebird bio, Kristina worked at Biogen, where they held multiple positions including Director of COPL and Research & Development Program Lead (RDPL) from May 2019 to January 2021, Associate Director of Clinical Operations Program Leadership (COPL) from May 2017 to May 2019, and Senior Manager of Clinical Operations Lead from July 2013 to May 2017.

Kristina began their career in the pharmaceutical industry at Genzyme, where they worked as a Senior Clinical Research Associate from April 2003 to December 2006, and as a Clinical Research Coordinator/CRA from October 2001 to April 2003. Kristina also gained experience as a Clinical Study/Project Manager at Quintiles from January 2007 to September 2010, and as a Senior Clinical Project Manager at AVEO Oncology from September 2011 to July 2013. Overall, Kristina Johnson has a strong background in managing and leading clinical operations in the biotechnology and pharmaceutical industries.

Kristina Johnson completed their undergraduate studies at Colby College from 1993 to 1997, where they earned a Bachelor of Arts (B.A.) degree in Biochemistry. In 1999, they pursued further education at Northeastern University, but the available information does not provide details about the degree or field of study. Later, in 2002 and 2003, they attended Boston University and obtained a Certificate in Clinical Research.